医師と患者をつなぐ医療・ヘルスケアプラットフォーム｜2,000以上の病気の情報と医師・病院情報を掲載

伊藤病院内科部長

日本内科学会総合内科専門医日本内分泌学会内分泌代謝科（内科）専門医・内分泌代謝科指導医・内分泌代謝・糖尿病内科領域専門研修指導医・評議員日本甲状腺学会認定専門医・評議員・理事日本糖尿病学会糖尿病専門医臨床遺伝専門医制度委員会臨床遺伝専門医

渡邊奈津子わたなべなつこ先生

東京都

公開日: 2022/09/16

基本情報
来歴等

基本情報

診療科・主な得意領域

バセドウ病
詳細
渡邊先生のバセドウ病の専門領域
- 薬物療法（抗甲状腺薬治療・無機ヨウ素治療）
- 放射性ヨウ素内用療法（アイソトープ治療）
甲状腺機能低下症
詳細
渡邊先生の甲状腺機能低下症の専門領域
- 甲状腺ホルモン補充療法

【診療科】内分泌科
【得意な領域】甲状腺
【疾患名】橋本病（慢性甲状腺炎）【治療法】甲状腺ホルモン補充療法
【疾患名】甲状腺機能性結節【治療法】放射性ヨウ素内用療法（アイソトープ治療）、薬物療法
【疾患名】妊娠合併甲状腺疾患【治療法】薬物療法

資格・学会・役職

日本内科学会	総合内科専門医
日本内分泌学会	内分泌代謝科（内科）専門医・内分泌代謝科指導医・内分泌代謝・糖尿病内科領域専門研修指導医・評議員
日本甲状腺学会	認定専門医・評議員・理事
日本糖尿病学会	糖尿病専門医
臨床遺伝専門医制度委員会	臨床遺伝専門医

伊藤病院内科部長

所属病院

伊藤病院

内科外科放射線科病理診断科
東京都渋谷区神宮前4丁目3-6
東京メトロ銀座線表参道 A2出口　　車イスの場合、A1出口の利用推奨徒歩2分 JR山手線原宿表参道改札東口徒歩15分
03-3402-7411

公式ウェブサイト

来歴等

略歴

1997年東邦大学医学部卒業
2009年東邦大学医学部内科学講座（大森）糖尿病・代謝・内分泌科助教
2010年伊藤病院内科
2016年伊藤病院内科医長
2022年伊藤病院内科部長

論文

1. Prediction model of Graves' disease in general clinical practice based on complete blood count and biochemistry profile. Endocr J. 2022 Apr 5. doi: 10.1507/endocrj.EJ21-0741. Online ahead of print.

A. Yoshihara, J. Y. Noh, K. Inoue, J. Taguchi, K. Hata, T. Aizawa, Y. T. Arai, N. Watanabe, M. Fukushita, M. Matsumoto, N. Suzuki, A. Hoshiyama, A. Suzuki, T. Mitsumatsu, A. Kinoshita, K. Mikura, R. Yoshimura, K. Sugino, Koichi Ito.
2. The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease. Thyroid. 2022;32:552-559.

N. Suzuki, N. Watanabe, J. Y. Noh, R. Yoshimura, K. Mikura, A. Kinoshita, A. Suzuki, T. Mitsumatsu, M. Fukushita, M. Matsumoto, A. Yoshihara, R. Katoh, K. Sugino, K. Ito.
3. Thyroid MALT lymphoma: self-harm to gain potential T-cell help. Leukemia. doi: 10.1038/s41375-021-01289-z, 2021, Online ahead of print.

F. Wu, N. Watanabe, M. M. Tzioni, A. Akarca. C. Zhang, Y. Li, Z.Chen, F. Cucco, N. Carmell, J. Y. Noh, K. Ito, R. Dobson, S. Moody, W. Yao, W. Zhang, W. Liu, H. Liu, J. Okosun, A. Chott, Y. Bi, S. S. Chuang, M. Raderer, J.Y. Li, T. Marafioti, M.Q.Du.
4. Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic. J Endocr Soc

K. Inoue, J. Y. Noh, A. Yoshihara, N. Watanabe, M. Matsumoto, M. Fukushita, N. Suzuki, A. Hoshiyama, T. Mitsumatsu, A. Suzuki, A. Kinoshita, K. Mikura, R. Yoshimura, K. Sugino, K. Ito.
5. Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association. Endocr J. doi:10.1507/endocrj. EJ21-0238, 2021, Online ahead of print.

N. Watanabe, J. Y. Noh, T. Akamizu, M. Yamada.
6. A case of macro-TSH consisting of IgA-bound TSH Endocr J. doi: 10.1507/endocrj.EJ21-0021, 2021 Online ahead of print.

M. Fukushita, N. Watanabe, J. Y. Noh, A. Yoshihara, M. Matsumoto, N. Suzuki, R. Yoshimura, K. Sugino, K. Ito.
7. Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc. 2021 Jan 19;5(3):bvaa204. doi: 10.1210/jendso/bvaa204. eCollection 2021 Mar 1.

A. Yoshihara, J. Y. Noh, N. Watanabe, M. Fukushita, M. Matsumoto, N. Suzuki, A. Hoshiyama, A. Suzuki, T. Mitsumatsu, A. Kinoshita, K. Mikura, R. Yoshimura, K. Sugino, K. Ito.
8. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease? Thyroid. doi: 10.1089/thy.2020.0881, 2021. Online ahead of print.

N. Suzuki, J. Y. Noh, R. Yoshimura, K. Mikura, A. Kinoshita, A. Suzuki, T. Mitsumatsu, A. Hoshiyama, M. Fukushita, M. Matsumoto, A. Yoshihara, N. Watanabe, K. Sugino, K. Ito.
9. Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease. Eur Thyroid J. DOI: 10.1159/000510619, 2020, online ahead of print.

N. Watanabe, J. Y. Noh, N. Hattori, K. Iwaku, N. Suzuki, A. Yoshihara, H. Ohye, M. Suzuki, M. Matsumoto, K. Endo, Y. Kunii, G. Takagi, K. Sugino, K. Ito.
10. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature. Endocr J. 68:145-151. 2020.

M. Hiruma, Y. Sasano, N. Watanabe, A. Yoshihara, S. Ishii, Y. Yaguchi, J. Y. Noh, K, Sugino, K. Ito.
11. Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease. Endocr J. 67:631-638, 2020.

N. Suzuki, J. Y. Noh, C. Sugisawa, A. Hoshiyama, M. Hiruma, A. Kawaguchi, M. Morisaki, H. Ohye, M. Suzuki, M. Matsumoto, Y. Kunii, A. Yoshihara, N. Watanabe, K. Sugino, K. Ito.
12. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy. Thyroid.30:451-456, 2020

A. Yoshihara, J. Y. Noh, N. Watanabe, Y. Kunii, M. Suzuki, M. Matsumoto, N. Suzuki, M. Hiruma, M. Morisaki, A. Kawaguchi, K. Sugino K. Ito.
13. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan. Thyroid. 29:1390-1398, 2019

N. Suzuki, J. Y. Noh, M. Hiruma, A. Kawaguchi, M. Morisaki, H. Ohye, M. Suzuki, M. Matsumoto, Y. Kunii, K. Iwaku, A. Yoshihara, N. Watanabe, K. Sugino, K. Ito.
14. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan. J Clin Endocrinol Metab. 103:732-9, 2018

N. Watanabe, H. Narimatsu, J. Y. Noh, K. Iwaku, Y. Kunii, N. Suzuki, H. Ohye, M. Suzuki, M. Matsumoto, A. Yoshihara, K. Kameyama, K. Kobayashi, M. Kami, K. Sugino, K. Ito.
15. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. Thyroid 25: 1155-1161, 2015

A. Yoshihara, J. Y. Noh, N. Watanabe, K. Mukasa, H. Ohye, M. Suzuki, M. Matsumoto, Y. Kunii, N. Suzuki, T. Kameda, K. Iwaku, S. Kobayashi, K. Sugino, K. Ito.
16. Radioiodine-Associated Exacerbation of Graves’ Orbitopathy in the Japanese Population: Randomized Prospective Study. J Clin Endocrinol Metab 100 : 2700-2708, 2015

N. Watanabe, J. Y. Noh, A. Kozaki, K. Iwaku, K. Sekiya, Y. Kosuga, M. Matsumoto, M. Suzuki, A. Yoshihara, H. Ohye, S. Kobayashi, Y. Kunii, K. Mukasa, K. Sugino, T. Inoue, K. Ito.
17. Rituximab-including combined modality treatment for primary thyroid lymphoma: an effective regimen for elderly patients. Thyroid 24: 994-999,2014

N. Watanabe, H. Narimatsu H, J.Y. Noh, Y. Kunii, K. Mukasa, M. Matsumoto, M. Suzuki, K. Sekiya, H. Ohye, A. Yoshihara, K. Iwaku, S. Kobayashi, K. Kameyama, K. Kobayashi, Y. Nishikawa, M. Kami, K. Sugino, K. Ito.
18. Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease. J Clin Endocrinol Metab 97: E49-E53, 2012 (JCEM On-Line).

N. Watanabe, H. Narimatsu, J.Y. Noh, T. Yamaguchi, K. Kobayashi, M. Kami, Y. Kunii, K. Mukasa, K. Ito, K. Ito.
19. Treatment of Graves' disease with antithyroid drugs in the first trimester of paregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 97: 2396-2403, 2012.

A. Yoshihara, J. Y. Noh, T. Yamaguchi, H. Ohye, Siori. Sato, K. Sekiya, Y. Kosuga, Miho suzuki, M. Matsumoto, Y. Kunii, N. Watanabe, K. Mukasa, K. Ito, K. Ito.
20. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease. British Journal of Haemaology 153: 236-243, 2011

N. Watanabe, J. Y. Noh, H. Narimatsu, K. Takeuch, T. Yamaguchi, K. Kameyama, K. Kobayashi, M. Kami, A. Kubo, Y. Kunii, T. Shimizu, K. Mukasa, F. Otsuka, A. Miyara, A. Minagawa, K. Ito, K. Ito.